Next Article in Journal
Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine
Previous Article in Journal
Targeting Toll-Like Receptor 2: Polarization of Porcine Macrophages by a Mycoplasma-Derived Pam2cys Lipopeptide
Expression of Concern published on 28 June 2021, see Vaccines 2021, 9(7), 705.
Retraction published on 2 July 2021, see Vaccines 2021, 9(7), 729.
Article

The Safety of COVID-19 Vaccinations—We Should Rethink the Policy

1
Poznan University of the Medical Sciences, Pediatric Hospital, 60-572 Poznan, Poland
2
Department of Psychology, University of Witten/Herdecke, 58448 Witten, Germany
3
Change Health Science Institute, 10178 Berlin, Germany
4
Department of Radiation Oncology, Leopoldina Hospital, 97422 Schweinfurt, Germany
5
Independent Data and Pattern Scientist, Brinkenbergweg 1, 7351 BD Hoenderloo, The Netherlands
*
Author to whom correspondence should be addressed.
Academic Editor: Ralph J. DiClemente
Vaccines 2021, 9(7), 693; https://doi.org/10.3390/vaccines9070693
Received: 2 June 2021 / Revised: 19 June 2021 / Accepted: 21 June 2021 / Published: 24 June 2021
(This article belongs to the Section COVID-19 Vaccines and Vaccination)
Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and benefits. Method: We calculated the number needed to vaccinate (NNTV) from a large Israeli field study to prevent one death. We accessed the Adverse Drug Reactions (ADR) database of the European Medicines Agency and of the Dutch National Register (lareb.nl) to extract the number of cases reporting severe side effects and the number of cases with fatal side effects. Result: The NNTV is between 200–700 to prevent one case of COVID-19 for the mRNA vaccine marketed by Pfizer, while the NNTV to prevent one death is between 9000 and 50,000 (95% confidence interval), with 16,000 as a point estimate. The number of cases experiencing adverse reactions has been reported to be 700 per 100,000 vaccinations. Currently, we see 16 serious side effects per 100,000 vaccinations, and the number of fatal side effects is at 4.11/100,000 vaccinations. For three deaths prevented by vaccination we have to accept two inflicted by vaccination. Conclusions: This lack of clear benefit should cause governments to rethink their vaccination policy. View Full-Text
Keywords: SARS-CoV2; COVID-19; vaccination; mRNA-vaccine; number needed to vaccinate; safety; side effects; adverse drug reaction; fatal side effects; EMA SARS-CoV2; COVID-19; vaccination; mRNA-vaccine; number needed to vaccinate; safety; side effects; adverse drug reaction; fatal side effects; EMA
Show Figures

Figure 1

MDPI and ACS Style

Walach, H.; Klement, R.J.; Aukema, W. The Safety of COVID-19 Vaccinations—We Should Rethink the Policy. Vaccines 2021, 9, 693. https://doi.org/10.3390/vaccines9070693

AMA Style

Walach H, Klement RJ, Aukema W. The Safety of COVID-19 Vaccinations—We Should Rethink the Policy. Vaccines. 2021; 9(7):693. https://doi.org/10.3390/vaccines9070693

Chicago/Turabian Style

Walach, Harald, Rainer J. Klement, and Wouter Aukema. 2021. "The Safety of COVID-19 Vaccinations—We Should Rethink the Policy" Vaccines 9, no. 7: 693. https://doi.org/10.3390/vaccines9070693

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop